Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension

Completed · Phase 2/Phase 3

Conditions studied: Open-angle Glaucoma, Oular Hypertension

In brief

The purpose of this study was to evaluate the safety and intraocular-lowering efficacy of anecortave acetate depot when administered by anterior juxtascleral depot (AJD) for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT00691717

Run by

Alcon Research

People needed

201

Starts

2008-06-01

Expected to finish

2009-09-01

Last updated by the study team

2012-11-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years of age or older with open-angle glaucoma (with or without pigment dispersion or pseudoexfoliation) or ocular hypertension.
• Other protocol-defined inclusion criteria may apply.

You may not qualify if…

• Patients with any form of glaucoma other than open-angle.
• Other protocol-defined exclusion criteria may apply.

Where it is running

• Charleston — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.